Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre

Trine Honnens de Lichtenberg; Gregers G. Hermann; Mikael Rorth; Mari-Janne Hojer Larsen; Zahra Mansourvar; Mette L. Holm; Thomas Scheike

doi:10.3109/21681805.2013.876550

Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre

Trine Honnens de Lichtenberg, Gregers G. Hermann, Mikael Rorth, Mari-Janne Hojer Larsen, Zahra Mansourvar, Mette L. Holm, Thomas Scheike

9 Citations (Scopus)

Original language	English
Journal	Scandinavian Journal of Urology and Nephrology
Volume	48
Issue number	4
Pages (from-to)	379-386
ISSN	2168-1805
DOIs	https://doi.org/10.3109/21681805.2013.876550
Publication status	Published - Aug 2014

Keywords

immunotherapy
metastasectomy
metastatic renal cancer
prognosis
risk groups
tyrosine kinase inhibitors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/21681805.2013.876550

Cite this

de Lichtenberg, T. H., Hermann, G. G., Rorth, M., Larsen, M-J. H., Mansourvar, Z., Holm, M. L., & Scheike, T. (2014). Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre. Scandinavian Journal of Urology and Nephrology, 48(4), 379-386. https://doi.org/10.3109/21681805.2013.876550

Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer : outcome of 143 consecutive patients from a single centre. / de Lichtenberg, Trine Honnens; Hermann, Gregers G.; Rorth, Mikael et al.

In: Scandinavian Journal of Urology and Nephrology, Vol. 48, No. 4, 08.2014, p. 379-386.

Research output: Contribution to journal › Journal article › Research › peer-review

de Lichtenberg, TH, Hermann, GG, Rorth, M, Larsen, M-JH, Mansourvar, Z, Holm, ML & Scheike, T 2014, 'Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre', Scandinavian Journal of Urology and Nephrology, vol. 48, no. 4, pp. 379-386. https://doi.org/10.3109/21681805.2013.876550

@article{b98bc218fc9b410e82b3f92a26cef93b,

title = "Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre",

keywords = "immunotherapy, metastasectomy, metastatic renal cancer, prognosis, risk groups, tyrosine kinase inhibitors",

author = "{de Lichtenberg}, {Trine Honnens} and Hermann, {Gregers G.} and Mikael Rorth and Larsen, {Mari-Janne Hojer} and Zahra Mansourvar and Holm, {Mette L.} and Thomas Scheike",

year = "2014",

month = aug,

doi = "10.3109/21681805.2013.876550",

language = "English",

volume = "48",

pages = "379--386",

journal = "Scandinavian Journal of Urology",

issn = "2168-1805",

publisher = "Taylor & Francis",

number = "4",

}

TY - JOUR

T1 - Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer

T2 - outcome of 143 consecutive patients from a single centre

AU - de Lichtenberg, Trine Honnens

AU - Hermann, Gregers G.

AU - Rorth, Mikael

AU - Larsen, Mari-Janne Hojer

AU - Mansourvar, Zahra

AU - Holm, Mette L.

AU - Scheike, Thomas

PY - 2014/8

Y1 - 2014/8

KW - immunotherapy

KW - metastasectomy

KW - metastatic renal cancer

KW - prognosis

KW - risk groups

KW - tyrosine kinase inhibitors

U2 - 10.3109/21681805.2013.876550

DO - 10.3109/21681805.2013.876550

M3 - Journal article

C2 - 24521185

SN - 2168-1805

VL - 48

SP - 379

EP - 386

JO - Scandinavian Journal of Urology

JF - Scandinavian Journal of Urology

IS - 4

ER -

Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this